ArticleScientific reports2025
Stochastic modeling and first-passage-time analysis of oncological time metrics with dynamic tumor barriers.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quantitative dual-layer spectral CT parameters associated with a continuous improvement response pattern to CAPTEM in advanced gastroenteropancreatic neuroendocrine neoplasms.Abdominal radiology (New York) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The first-passage-time (FPT) that a tumor size reaches a particular barrier is important in evaluating the efficacy of anti-cancer therapies and understanding certain oncological time occurrences. For certain verified stochastic models describing the volume of a tumor, a moving barrier for the tumor size in which an explicit solution of an FPT probability density function (PDF) exists for the first time the tumor size reaches the moving barrier is obtained in this work. The stochastic tumor dynamics incorporate anti-cancer therapies/treatments that are administered at varying rates. The first-passage-time density (FPTD) is derived and utilized to determine the time at which the tumor volume first reaches the moving barrier, providing a framework for analyzing various oncological time metrics. These metrics include key time measurements used to characterize tumor progression, evaluate treatment response, and capture recurrence patterns in cancer dynamics. The treatment effort needed to cause reduction in tumor size is also obtained. We obtained, for a tumor growing initially, the FPTD for the random variables describing the first time that the growth of the tumor starts slowing down following the commencement of treatment, the first time that the tumor starts showing signs of shrinkage after the start of treatment, the first time it takes for the reduction in tumor to start slowing down, and the first time for tumor recurrence after partial remission. This work is applied to experimental data including the Murine Lewis Lung Carcinoma cells originally derived from a spontaneous tumor in twenty control mice. The time at which the volume of the tumor of each mouse doubles in size is estimated using the results obtained in this study. Additionally, tumor volume experiments conducted on another eight control mice are used to validate the findings derived in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.